ClinicalTrials.Veeva

Menu

A Cohort Study of Hydatidiform Mole

W

Women's Hospital School Of Medicine Zhejiang University

Status

Not yet enrolling

Conditions

Hydatidiform Mole

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05637892
IRB-20220312-R

Details and patient eligibility

About

The purpose of this study is to construct a cohort for the hydatidiform mole.

Full description

After being informed about the study and potential risks, all patients who meet the eligibility requirements will be enrolled.

Enrollment

800 estimated patients

Sex

Female

Ages

13 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients who are diagnosed with hydatidiform mole (including: complete hydatidiform mole/partial hydatidiform mole; one of twins with hydatidiform mole; ectopic pregnancy hydatidiform mole; macroscopic or microscopic hydatidiform changes indicating early complete or partial hydatidiform mole can not be excluded; atypical placental site nodule) for the first time;
  2. Age 13-55 years old;
  3. Obtain informed consent and sign an informed consent form

Exclusion criteria

  1. Patients who are unable to cooperate with the investigation such as mental disorders or cognitive impairment
  2. No histopathology diagnosis;
  3. Patients with other malignancies

Trial contacts and locations

0

Loading...

Central trial contact

Weiguo Lv, PhD; Xiao Li, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems